News
The New Times on MSN1h
How can Rwandans acquire new HIV preventive drug at a lower price?
Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries. Manufactured by US ...
Gandhi cited a recent study from the CDC showing that more than 2.2 million individuals in the US need PrEP, but only 336K ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback